Jane Street
CTXR icon

Jane Street’s Citius Pharmaceuticals CTXR Stock Holding History

Jane Street’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.5K Buy
+23,900
New +$19.3K ﹤0.01% 11185
2021
Q4 		– Sell
-1,024
Closed -$52K – 10159
2021
Q3 		$52K Buy
+1,024
New +$51.4K ﹤0.01% 9534

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street's CTXR Position: Q1 2026 in Review

Jane Street increased its Citius Pharmaceuticals (CTXR) stake by 25% in Q1 2026, buying an estimated $3.69K and bringing the position to 22,523 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #11189.

Jane Street first reported a position in CTXR in Q4 2019 and has held it in 14 quarters since. The position peaked at $288K in Q1 2023. 38 funds tracked by Wall St. Rank hold CTXR as of Q1 2026.

  • Jane Street held 22,523 shares of Citius Pharmaceuticals worth $20.3K as of Q1 2026.
  • Jane Street bought 4,565 Citius Pharmaceuticals shares in Q1 2026, an estimated $3.69K.
  • Citius Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11189 holding.
  • Jane Street first reported a position in Citius Pharmaceuticals in Q4 2019 and has held it in 14 quarters since.
  • Jane Street's Citius Pharmaceuticals position peaked at $288K in Q1 2023.
  • 38 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.